NASDAQ:ACXP

Acurx Pharmaceuticals Stock Forecast

etoro logo Buy ACXP
*Your capital is at risk
$1.44
+0.0200 (+1.41%)
At Close: Jul 31, 2026
AI Analysis AI Analysis of ACXP AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ACXP to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Acurx Pharmaceuticals, Inc. stock price ended at $1.44 on Friday, after gaining 1.41%
(Updated on Jul 31, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 17, 2026 Loss -7.10%

The Acurx Pharmaceuticals, Inc. stock price gained 1.41% on the last trading day (Friday, 31st Jul 2026), rising from $1.42 to $1.44. During the last trading day the stock fluctuated 4.35% from a day low at $1.38 to a day high of $1.44. The price has fallen in 6 of the last 10 days and is down by -7.1% for this period. Volume fell on the last day by -82 thousand shares and in total, 27 thousand shares were bought and sold for approximately $39.46 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -30.14% during the next 3 months and, with a 90% probability hold a price between $0.81 and $1.13 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ACXP Signals & Forecast

There are mixed signals in the stock today. The Acurx Pharmaceuticals, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.52. On a fall, the stock will find some support from the short-term average at $1.42. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Wednesday, July 08, 2026, and so far it has risen 5.88%. Further rise is indicated until a new top pivot has been found.

Support, Risk & Stop-loss for Acurx Pharmaceuticals, Inc. stock

Acurx Pharmaceuticals, Inc. finds support from accumulated volume at $1.42 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0600 between high and low, or 4.35%. For the last week the stock has had daily average volatility of 4.57%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ACXP) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Acurx Pharmaceuticals, Inc. to open at $1.42, and during the day (based on 14 day Average True Range), to move between $1.39 and $1.49, which gives a possible trading interval of +/-$0.100 (+/-7.22%) up or down from last closing price. If Acurx Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 7.22% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.45 (0.69%) than the support at $1.42 (1.39%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Acurx Pharmaceuticals, Inc. will release earnings BMO on Monday, August 10, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.420. We will update the financials statements for Acurx Pharmaceuticals, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 12.40% in the first trading day after earnings release.

Is Acurx Pharmaceuticals, Inc. stock A Buy?

Acurx Pharmaceuticals, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.544 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $1.42 ( 1.39%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ACXP Performance

Trading levels for ACXP

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.48 2.78%
R2 1.46 1.19%
R1 1.44 0.203%
Price 1.44
S1 1.40 -2.98%
S2 1.38 -3.96%
S3 1.36 -5.56%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.75 21.53%
R2 1.68 16.67%
R1 1.45 0.694%
Price 1.44
S1 1.42 -1.39%
S2 1.39 -3.47%
S3 1.36 -5.56%

FAQ

What is the symbol for Acurx Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Acurx Pharmaceuticals, Inc. is ACXP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Acurx Pharmaceuticals, Inc. Stock?
Acurx Pharmaceuticals, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Acurx Pharmaceuticals, Inc. Stock?
Acurx Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Acurx Pharmaceuticals, Inc. Stock.

What's the current price of Acurx Pharmaceuticals, Inc. Stock?
As of the end of day on the Jul 31, 2026, the price of an Acurx Pharmaceuticals, Inc. (ACXP) share was $1.44.

What is the 52-week high and low for Acurx Pharmaceuticals, Inc. Stock?
The 52-week high for Acurx Pharmaceuticals, Inc. Stock is $8.34 and the 52-week low is $0.280.

What is the market capitalization of Acurx Pharmaceuticals, Inc. Stock?
As of the Jul 31, 2026, the market capitalization of Acurx Pharmaceuticals, Inc. is 2.282M.

When is the next earnings date for Acurx Pharmaceuticals, Inc.?
The upcoming earnings date for Acurx Pharmaceuticals, Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT ACURX PHARMACEUTICALS, INC.
Acurx Pharmaceuticals
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bac...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE